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Published data from our laboratory indicate that estrogen-deficient postmenopausal women have an 
augmented blood pressure response to voluntary apnea compared to premenopausal women. This finding 
could have clinical relevance since transient surges in blood pressure are thought to be an important 
stimulus for end-organ damage in obstructive sleep apnea (i.e., a disease that is more common in older 
adults). Both obstructive sleep apnea and the healthy aging process are associated with an increase in 
oxidative stress, which may impair reflex cardiovascular responses. PURPOSE: To determine the effect 
of acute antioxidant infusion on physiological responses to voluntary apnea in healthy postmenopausal 
women. METHODS: Eight healthy postmenopausal women (64 ± 2 yr) provided written informed 
consent to participate. Studies were performed in the supine posture following intravenous infusion of 
normal saline (100 mL) and ascorbic acid (3500 mg/in 100 mL); each subject received both infusions 
approximately 1 hour apart. Beat-by-beat mean arterial pressure (MAP), heart rate (HR), and brachial 
artery blood flow velocity (BBFV, Doppler ultrasound) were measured throughout the study. Subjects 
performed maximal voluntary end expiratory apneas and peak changes (Δ) from baseline were compared 
between infusions. RESULTS: The breath hold duration and oxygen saturation nadir were similar 
between saline (29 ± 6 s, 94 ± 1 %) and ascorbic acid (29 ± 5 s, 94 ±1 %). Ascorbic acid attenuated the 
pressor response to voluntary apnea (ΔMAP: 6 ± 2 mmHg) as compared to saline (ΔMAP: 12 ± 2 mmHg, 
P= 0.034) and also attenuated forearm vasoconstriction (ΔBBFV: 4 ± 9 versus -12 ± 7%, P = 0.049) but 
did not affect ΔHR (2 ± 1 vs. 0 ± 2 bpm). CONCLUSION: Ascorbic acid lowered the blood pressure 
response to voluntary apnea in postmenopausal women by inhibiting vasoconstriction in the limb 
vasculature. Whether ascorbic acid has similar effects in patients with sleep apnea remains to be 
prospectively tested.  
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